Noncoding RNAs in subchondral bone osteoclast function and their therapeutic potential for osteoarthritis

Arthritis Res Ther. 2020 Nov 25;22(1):279. doi: 10.1186/s13075-020-02374-x.

Abstract

Osteoclasts are the only cells that perform bone resorption. Noncoding RNAs (ncRNAs) are crucial epigenetic regulators of osteoclast biological behaviors ranging from osteoclast differentiation to bone resorption. The main ncRNAs, including miRNAs, circRNAs, and lncRNAs, compose an intricate network that influences gene transcription processes related to osteoclast biological activity. Accumulating evidence suggests that abnormal osteoclast activity leads to the disturbance of subchondral bone remodeling, thus initiating osteoarthritis (OA), a prevalent joint disease characterized mainly by cartilage degradation and subchondral bone remodeling imbalance. In this review, we delineate three types of ncRNAs and discuss their related complex molecular signaling pathways associated with osteoclast function during bone resorption. We specifically focused on the involvement of noncoding RNAs in subchondral bone remodeling, which participate in the degradation of the osteochondral unit during OA progression. We also discussed exosomes as ncRNA carriers during the bone remodeling process. A better understanding of the roles of ncRNAs in osteoclast biological behaviors will contribute to the treatment of bone resorption-related skeletal diseases such as OA.

Keywords: Noncoding RNAs; Osteoarthritis; Osteoclasts; Subchondral bone remodeling.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Bone Remodeling / genetics
  • Bone Resorption* / genetics
  • Cartilage, Articular*
  • Humans
  • Osteoarthritis* / genetics
  • Osteoarthritis* / therapy
  • Osteoclasts*
  • RNA, Untranslated / genetics*
  • RNA, Untranslated / therapeutic use

Substances

  • RNA, Untranslated